Deep Receipts
Trump administration policies
4 outlets covering this story, sorted by lean.
Carried by the left. The right is largely absent here.
Mixed evidence — a developing, contested story
The left is carrying this alone and the evidence is mixed. Read the receipts below and weigh it yourself.
1.3/10
Avg credibility
5
Facts extracted
2
Misleading flags
None
Primary source
A rules-based read of the 3 left-leaning reports carrying this story — derived from our per-article scoring (credibility, fact density, misleading elements, sourcing), not an editorial verdict. The receipts are below; weigh them yourself.
Left · 3
- The Trump Administration’s Plan for Protecting Consumers? Politely Ask Companies to Behave.propublica.org · cred 4/10
<p>The post <a href="https://www.propublica.org/article/bilt-cfpb-russell-vought-trump-consumer-protection-fintech">The Trump Administration’s Plan for Protecting Consumers? Politely Ask Companies to Behave.</a> appeared first on <a href="https://www.propublica.org">ProPublica</a>.</p>
- · Russell Vought testified before Congress in mid-July.
- · Russell Vought has served as acting head of the Consumer Financial Protection Bureau (CFPB).
- How the Pentagon Is Getting Into the Venezuelan Oil Business Under Trumpnytimes.com · cred 0/10
The Defense Department’s Office of Strategic Capital, founded by the Biden administration to give loans to bolster the U.S. defense industry, is helping lead President Trump’s oil deal.
- Donald Trump Jr.’s Firm Leads $1 Billion Funding Round for Polymarketnytimes.com · cred 0/10
The new round values the prediction market at $21 billion, up from $15 billion. Mr. Trump’s firm, 1789 Capital, will invest around $300 million.
Center / Wire · 1
- Trump strikes new drug pricing deals with nine midsized drugmakerscnbc.com · cred 6/10
The string of deals builds on the Trump administration's push to link the nation's drug prices to cheaper ones abroad.
- · President Trump announced deals with nine drugmakers: Alcon, Astellas Pharma, BeOne Medicines, BridgeBio, CSL, Kyowa Kirin, Sun Pharma, Teva Pharmaceuticals, and UCB.
- · The companies agreed to provide discounts on outpatient drugs to state Medicaid programs to align US prices with foreign prices.
Right · 0
—